Liontrust Investment Partners LLP Has $1.92 Million Position in Astera Labs, Inc. $ALAB

Key Points

• Liontrust Investment Partners LLP increased its holdings in Astera Labs by 100.3%, acquiring an additional 16,092 shares during the 1st quarter, bringing their total to 32,129 shares valued at approximately $1.9 million.
• Multiple institutional investors, including Vanguard Group Inc. and Driehaus Capital Management, have significantly increased their positions in Astera Labs, indicating strong institutional interest.
• Astera Labs recently reported earnings that exceeded analysts' expectations, with a quarterly revenue of $191.93 million, a 149.5% year-over-year increase, and a consensus rating of "Moderate Buy" from analysts.

Liontrust Investment Partners LLP grew its position in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 100.3% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 32,129 shares of the company's stock after purchasing an additional 16,092 shares during the quarter. Liontrust Investment Partners LLP's holdings in Astera Labs were worth $1,917,000 as of its most recent filing with the SEC.

Several other large investors have also modified their holdings of the stock. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in Astera Labs by 2,824.4% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 154,524 shares of the company's stock worth $20,467,000 after purchasing an additional 149,240 shares in the last quarter. Aigen Investment Management LP boosted its position in Astera Labs by 50.9% during the first quarter. Aigen Investment Management LP now owns 17,920 shares of the company's stock worth $1,069,000 after acquiring an additional 6,045 shares during the last quarter. Pacific Point Advisors LLC increased its stake in Astera Labs by 75.0% in the first quarter. Pacific Point Advisors LLC now owns 7,000 shares of the company's stock valued at $418,000 after purchasing an additional 3,000 shares during the last quarter. Oppenheimer Asset Management Inc. lifted its holdings in shares of Astera Labs by 73.6% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 15,995 shares of the company's stock worth $954,000 after acquiring an additional 6,783 shares during the period. Finally, Taylor Frigon Capital Management LLC acquired a new position in shares of Astera Labs in the 1st quarter valued at $1,887,000. Hedge funds and other institutional investors own 60.47% of the company's stock.

Insider Activity

In other news, CEO Jitendra Mohan sold 152,517 shares of the firm's stock in a transaction dated Thursday, August 7th. The shares were sold at an average price of $170.33, for a total transaction of $25,978,220.61. Following the completion of the transaction, the chief executive officer directly owned 450,001 shares of the company's stock, valued at approximately $76,648,670.33. This trade represents a 25.31% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Sanjay Gajendra sold 280,000 shares of the stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of $170.02, for a total transaction of $47,605,600.00. Following the sale, the chief operating officer owned 5,525,545 shares of the company's stock, valued at $939,453,160.90. This trade represents a 4.82% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 2,385,416 shares of company stock valued at $298,063,981. Insiders own 12.50% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the stock. Wall Street Zen upgraded shares of Astera Labs from a "hold" rating to a "buy" rating in a report on Saturday. Needham & Company LLC lifted their price target on shares of Astera Labs from $100.00 to $170.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. Stifel Nicolaus set a $145.00 price target on Astera Labs and gave the company a "buy" rating in a research report on Monday, August 4th. Morgan Stanley raised their price target on Astera Labs from $125.00 to $155.00 and gave the stock an "overweight" rating in a report on Wednesday, August 6th. Finally, Zacks Research upgraded shares of Astera Labs to a "strong-buy" rating in a research report on Tuesday, August 12th. One research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, Astera Labs currently has an average rating of "Moderate Buy" and an average price target of $129.13.

Astera Labs Trading Up 0.8%

ALAB stock traded up $1.39 during midday trading on Wednesday, reaching $172.45. The company had a trading volume of 5,882,500 shares, compared to its average volume of 6,419,961. Astera Labs, Inc. has a 1 year low of $36.85 and a 1 year high of $199.47. The company has a 50 day moving average of $120.52 and a two-hundred day moving average of $91.84. The company has a market capitalization of $28.66 billion, a P/E ratio of 307.95, a PEG ratio of 4.34 and a beta of 1.39.

Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.33 by $0.11. The business had revenue of $191.93 million during the quarter, compared to analyst estimates of $172.46 million. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The firm's revenue was up 149.5% on a year-over-year basis. During the same period in the previous year, the company earned $0.13 EPS. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. On average, sell-side analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.